• Phone: +1-631-791-1145
                  • Email: sales@imarcgroup.com

                  *As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

                  Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

                  Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D cycle is cheaper and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited price erosion and significantly higher profit margins.

                  Global Generic Injectables Market Research Report

                  Owing to the advantages offered by generic injectables, governments in various countries are supporting their manufacture. Additionally, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population and rising prevalence of chronic as well as lifestyle diseases represent some of the other factors driving the growth of the market. According to IMARC Group’s latest report titled, “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global generic injectables market reached a value of US$ 31.7 Billion in 2019. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2020-2025.

                  The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share. On a regional-basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the global market. The report has also analysed the competitive landscape of the market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter.

                  This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.

                  Key Questions Answered in This Report:

                  • How has the generic injectables market performed so far and how will it perform in the coming years?
                  • What has been the impact of COVID-19 on the global generic injectables industry?
                  • What are the key regional markets in the global generic injectables industry?
                  • What are the price trends of generic injectables?
                  • What are the various stages in the value chain of the generic injectables industry?
                  • What are the key driving factors and challenges in the generic injectables industry?
                  • What is the structure of the global generic injectables industry and who are the key players?
                  • What is the degree of competition in the global generic injectables industry?
                  • What are the profit margins in the generic injectables industry?
                  • What are the key requirements for setting up a generic injectables manufacturing plant?
                  • How are generic injectables manufactured?
                  • What are the various unit operations involved in a generic injectables manufacturing plant?
                  • What is the total size of land required for setting up a generic injectables manufacturing plant?
                  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
                  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
                  • What are the packaging requirements for generic injectables?
                  • What are the transportation requirements for generic injectables?
                  • What are the utility requirements for setting up a generic injectables manufacturing plant?
                  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
                  • What are the infrastructure costs for setting up a generic injectables manufacturing plant?
                  • What are the capital costs for setting up a generic injectables manufacturing plant?
                  • What are the operating costs for setting up a generic injectables manufacturing plant?
                  • What will be the income and expenditures for a generic injectables manufacturing plant?
                  • What is the time required to break-even?

                  1 Preface
                  2 Scope and Methodology

                      2.1 Objectives of the Study
                      2.2 Stakeholders
                      2.3 Data Sources
                          2.3.1 Primary Sources
                          2.3.2 Secondary Sources
                      2.4 Market Estimation
                          2.4.1 Bottom-Up Approach
                          2.4.2 Top-Down Approach
                      2.5 Forecasting Methodology
                  3 Executive Summary
                  4 Introduction

                      4.1 Overview    
                      4.2 Key Industry Trends
                  5 Global Generic Drug Market
                      5.1 Market Overview
                      5.2 Market Performance
                      5.3 Market Breakup by Region
                      5.4 Market Forecast
                      5.5 Major Players
                  6 Global Generic Drug Delivery Market
                      6.1 Oral
                      6.2 Injectables   
                      6.3 Dermal/Topical
                      6.4 Inhalers
                  7 Global Generic Injectables Market
                      7.1 Market Overview
                      7.2 Market Performance
                      7.3 Impact of COVID-19
                      7.4 Market Breakup by Region
                      7.5 Market Breakup by Therapeutic Area
                      7.6 Market Breakup by Container
                      7.7 Market Breakup by Distribution Channel
                      7.8 Market Forecast
                      7.9 SWOT Analysis
                          7.9.1 Overview
                          7.9.2 Strengths
                          7.9.3 Weaknesses
                          7.9.4 Opportunities
                          7.9.5 Threats
                      7.10 Value Chain Analysis
                      7.11 Porter’s Five Forces Analysis
                          7.11.1 Overview
                          7.11.2 Bargaining Power of Buyers
                          7.11.3 Bargaining Power of Suppliers
                          7.11.4 Degree of Competition
                          7.11.5 Threat of New Entrants
                          7.11.6 Threat of Substitutes
                       7.12 Key Market Drivers and Success Factors
                  8 Global Generic Injectables Market: Performance of Key Regions
                      8.1 North America
                          8.1.1 Market Trends
                          8.1.2 Market Forecast
                      8.2 Europe
                          8.2.1 Market Trends
                          8.2.2 Market Forecast
                      8.3 Asia
                          8.3.1 Market Trends
                          8.3.2 Market Forecast
                      8.4 Latin America
                          8.4.1 Market Trends
                          8.4.2 Market Forecast
                      8.5 Middle East and Africa
                          8.5.1 Market Trends
                          8.5.2 Market Forecast
                  9 Market by Therapeutic Area
                      9.1 Oncology
                          9.1.1 Market Trends
                          9.1.2 Market Forecast
                      9.2 Anaesthesia
                          9.2.1 Market Trends
                          9.2.2 Market Forecast
                      9.3 Anti-infectives
                          9.3.1 Market Trends
                          9.3.2 Market Forecast
                      9.4 Parenteral Nutrition
                          9.4.1 Market Trends
                          9.4.2 Market Forecast
                      9.5 Cardiovascular
                          9.5.1 Market Trends
                          9.5.2 Market Forecast
                  10 Market by Container
                       10.1 Vials
                          10.1.1 Market Trends
                          10.1.2 Market Forecast
                      10.2 Ampoules
                          10.2.1 Market Trends
                          10.2.2 Market Forecast
                      10.3 Premix
                          10.3.1 Market Trends
                          10.3.2 Market Forecast
                      10.4 Prefilled Syringes
                          10.4.1 Market Trends
                          10.4.2 Market Forecast
                  11 Market by Distribution Channel
                       11.1 Hospitals
                          11.1.1 Market Trends
                          11.1.2 Market Forecast
                      11.2 Retail Pharmacy 
                          11.2.1 Market Trends
                          11.2.2 Market Forecast
                  12 Global Generic Injectable Market: Competitive Landscape
                      12.1 Competitive Structure
                      12.2 Market Breakup by Key Players    
                  13 Generic Injectable Manufacturing Process
                      13.1 Product Overview
                      13.2 Detailed Process Flow (Injectable)
                      13.3 Various Types of Unit Operations Involved
                      13.4 Mass Balance and Raw Material Requirements
                  14 Project Details, Requirements and Costs Involved
                      14.1 Land Requirements and Expenditures
                      14.2 Construction Requirements and Expenditures
                      14.3 Plant Machinery
                      14.4 Machinery Pictures
                      14.5 Raw Material Requirements and Expenditures
                      14.6 Packaging Requirements and Expenditures
                      14.7 Transportation Requirements and Expenditures
                      14.8 Utility Requirements and Expenditures
                      14.9 Manpower Requirements and Expenditures
                      14.10 Other Capital Investments
                  15 Loans and Financial Assistance
                  16 Project Economics

                      16.1 Capital Cost of the Project
                      16.2 Techno-Economic Parameters
                      16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
                      16.4 Taxation and Depreciation
                      16.5 Income Projections
                      16.6 Expenditure Projections
                      16.7 Financial Analysis
                      16.8 Profit Analysis
                  17 Key Player Profiles
                       17.1 Hospira (Pfizer)
                           17.1.1 Company Overview
                           17.1.2 Product Portfolio
                           17.1.3 Financials
                           17.1.4 SWOT Analysis
                       17.2 Fresenius Kabi
                           17.2.1 Company Overview
                           17.2.2 Product Portfolio
                           17.2.3 Financials
                           17.2.4 SWOT Analysis
                       17.3 Hikma
                           17.3.1 Company Overview
                           17.3.2 Product Portfolio
                           17.3.3 Financials
                           17.3.4 SWOT Analysis
                       17.4 Sandoz (Novartis)
                           17.4.1 Company Overview
                           17.4.2 Product Portfolio
                           17.4.3 Financials
                           17.4.4 SWOT Analysis
                       17.5 Sagent
                           17.5.1 Company Overview
                           17.5.2 Product Portfolio
                           17.5.3 Financials
                           17.5.4 SWOT Analysis
                       17.6 Sanofi
                           17.6.1 Company Overview
                           17.6.2 Product Portfolio
                           17.6.3 Financials
                           17.6.4 SWOT Analysis
                       17.7 Baxter
                           17.7.1 Company Overview
                           17.7.2 Product Portfolio
                           17.7.3 Financials
                           17.7.4 SWOT Analysis


                  List of Figures

                  Figure 1: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2014 - 2019
                  Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2019
                  Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2020 - 2025
                  Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2014, 2019 & 2025
                  Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2014, 2019 & 2025
                  Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2014, 2019 & 2025
                  Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2014, 2019 & 2025
                  Figure 8: Global: Generic Injectables Market: Sales Value Trends (in Billion US$), 2014 - 2019
                  Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2019
                  Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2019
                  Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2019
                  Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2019
                  Figure 13: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2020 - 2025
                  Figure 14: Global: Generic Injectables Industry: SWOT Analysis
                  Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
                  Figure 16: Global: Generic Injectables Industry: Porter’s Five Forces Analysis
                  Figure 17: North America: Generic Injectable Market (in Million US$), 2014, 2019 & 2025
                  Figure 18: Europe: Generic Injectable Market (in Million US$), 2014, 2019 & 2025
                  Figure 19: Asia: Generic Injectable Market (in Million US$), 2014, 2019 & 2025
                  Figure 20: Latin America: Generic Injectable Market (in Million US$), 2014, 2019 & 2025
                  Figure 21: Middle East and Africa: Generic Injectable Market (in Million US$), 2014, 2019 & 2025
                  Figure 22: Global: Generic Injectable (Oncology) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 23: Global: Generic Injectable (Oncology) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 24: Global: Generic Injectable (Anaesthesia) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 25: Global: Generic Injectable (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 26: Global: Generic Injectable (Anti-infectives) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 27: Global: Generic Injectable (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 28: Global: Generic Injectable (Parenteral Nutrition) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 29: Global: Generic Injectable (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 30: Global: Generic Injectable (Cardiovascular) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 31: Global: Generic Injectable (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 32: Global: Generic Injectable (Vials) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 33: Global: Generic Injectable (Vials) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 34: Global: Generic Injectable (Ampoules) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 35: Global: Generic Injectable (Ampoules) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 36: Global: Generic Injectable (Premix) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 37: Global: Generic Injectable (Premix) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 38: Global: Generic Injectable (Prefilled Syringes) Market: Value Trends (in Million US$), 2014 & 2019
                  Figure 39: Global: Generic Injectable (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2020-2025
                  Figure 40: Global: Generic Injectable Market: Sales through Hospitals (in Million US$), 2014 & 2019
                  Figure 41: Global: Generic Injectable Market Forecast: Sales through Hospitals (in Million US$), 2020-2025
                  Figure 42: Global: Generic Injectable Market: Sales through Retail Pharmacy (in Million US$), 2014 & 2019
                  Figure 43: Global: Generic Injectable Market Forecast: Sales through Retail Pharmacy (in Million US$), 2020-2025
                  Figure 44: Generic Injectable Manufacturing Process: Conversion Rate of Feedstocks
                  Figure 45: Generic Injectable Manufacturing: Detailed Process Flow
                  Figure 46: Generic Injectable Manufacturing: Production Cost Breakup (in %)
                  Figure 47: Generic Injectable Industry: Profit Margins at Various Levels of the Supply Chain
                  Figure 48: Generic Injectable Manufacturing Plant: Proposed Plant Layout
                  Figure 49: Generic Injectable Manufacturing Plant: Breakup of Capital Costs (in %)


                  List of Tables

                  Table 1: Global: Generic Drug Market: Key Industry Highlights, 2019 and 2025
                  Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2020 - 2025
                  Table 3: Global: Generic Drug Market: Revenues of Key Players (in Million US$), 2019
                  Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2019 and 2025
                  Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2020 - 2025
                  Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2020 - 2025
                  Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2020 - 2025
                  Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2020 - 2025
                  Table 9: Generic Injectable Manufacturing Plant: Costs Related to Land and Site Development (in US$)
                  Table 10: Generic Injectable Manufacturing Plant: Costs Related to Civil Works (in US$)
                  Table 11: Generic Injectable Manufacturing Plant: Costs Related to Machinery Unit (in US$)
                  Table 12: Generic Injectable Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
                  Table 13: Generic Injectable Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
                  Table 14: Generic Injectable Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
                  Table 15: Details of Financial Assistance Offered by Financial Institutions
                  Table 16: Generic Injectable Manufacturing Plant: Capital Costs (in US$)
                  Table 17: Generic Injectable Manufacturing Plant: Techno-Economic Parameters (in US$)
                  Table 18: Generic Injectable Manufacturing Plant: Taxation and Depreciation (in US$)
                  Table 19: Generic Injectable Manufacturing Plant: Income Projections (in US$)
                  Table 20: Generic Injectable Manufacturing Plant: Expenditure Projections (in US$)
                  Table 21: Generic Injectable Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
                  Table 22: Generic Injectable Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
                  Table 23: Generic Injectable Manufacturing Plant: Profit and Loss Account (in US$)

                  Note: We value your privacy and will never rent or sell your email address. Privacy policy

                  Purchase Options




                  $ 2499

                  REACH OUT TO US

                  Call us on

                  ( US: +1-631-791-1145 )
                  ( UK: +44-702-409-7331 )
                  ( India: +91-120-433-0800 )


                  Drop us an email at

                  sales@imarcgroup.com

                  Social Links

                  大芭蕉天天视频在线观看